Servier Invests 1.33 Billion Euros In Muscle Disease Treatments
French pharmaceutical company Servier is investing 1.33 billion euros in treatments for muscular dystrophies. The company is focusing on these treatments as part of its research and development efforts.
Topics
Developing
- 882d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 882d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 882d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 882d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Mastodon
“Le laboratoire Servier mise 1,33 milliard d’euros sur des traitements contre les dystrophies musculaires”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade